J&J Vaccine Clot Issue Shows Limits of Clinical Trials, Scientists Say

WASHINGTON—Clinical trials are medicine’s way of deciding whether vaccines and drugs work, and how safe they are. But the studies

Read more

Coinbase Kicks Off a Week of 10 IPOs. What to Know.

Text size The cryptocurrency exchange Coinbase will trade on the Nasdaq. Dreamstime Coinbase isn’t the only company listing its shares

Read more

Chinese Auto Giant Geely Explores SPAC Deals

One of China’s largest car makers, Zhejiang Geely Holding Group Co., is making plans to tap into the surging market

Read more

Watch out Tesla. This new Mercedes-Benz ‘could be a game changer,’ says Deutsche Bank.

The newest all-electric luxury vehicle from Mercedes-Benz has the potential to improve the perception of the entire brand and will

Read more

Microsoft Bulks Up With $16 Billion Deal for Nuance Communications

Microsoft Corp. has agreed to buy artificial intelligence company Nuance Communications Inc. for $16 billion, extending Chief Executive Satya Nadella’s

Read more

Opinion: Should you buy Coinbase? The valuation is ridiculous, based on this math

Even though Coinbase’s revenue surged over the past 12 months, the company has little to no chance of meeting the

Read more

French Firms Strike $15.5 Billion Deal to Create Water, Waste-Management Behemoth

PARIS—France’s Veolia Environnement SA reached a $15.5 billion deal to acquire Suez SA, creating a water and waste-management giant that

Read more

Huawei, HSBC Strike Deal in Hong Kong Over Documents in Extradition Fight

HONG KONG—A monthslong legal fight by Huawei Technologies Co. Chief Financial Officer Meng Wanzhou to obtain documents from HSBC Holdings

Read more

Business unusual: wearable tech, touchless surfaces and office ‘mud rooms’

Still in the teeth of a deadly pandemic, the NBA’s San Antonio Spurs started the season on Dec. 23 with

Read more

Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says

An antibody drug from Regeneron Pharmaceuticals Inc. reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a

Read more